Search Videos and More
Medical oncologist Misako Nagasaka, MD
Jaime Landman, MD discusses a year of advancements in urology
UCI Medical Center is committed to excellence in urology.Pediatric ophthalmologist inspired to help disadvantaged children
Made with a 3D printer, these inexpensive spectacles provide vision correction for children with head or facial abnormalities who are unable to wear regular frames, as well as children whose families cannot afford traditional glasses.Concussion program director discusses long-term care for traumatic brain injury
Chen is the founding director of the UCI Health Traumatic Brain Injury & Concussion Program, the first in Orange County dedicated to providing longitudinal, multispecialty care for concussion and TBI patients.At the Forefront of Spine Surgery: Robotics, Biologics, & Clinical Trials at UCI Health
Nitin Bhatia, MD and Michael Oh, MD discuss the current state and future of spine care — from outpatient robotic surgery to motion-preserving implants and precision-driven biologics.Surgeon presents anterior-approach hip replacement and patient-specific knee replacement
Total hip arthroplasty is arguably one of the most successful and cost-effective procedures in Orthopaedics.Advances in catheter ablation
Hear from electrophysiologist on our advances in catheter ablation.UCI Health strongly represented at DDW 2025
Faculty and trainees present over 30 sessions at the nation’s largest digestive health conference, showcasing research and collaboration.Targeted therapy a game changer for metastatic breast cancer
Mohammadbagher Ziari, MD, used olaparib to successfully treat a patient's metastatic breast cancer which is now in remission.Pilot study tests ALS drug to treat chemo brain in cancer patients
A first-of-its-kind study tests ALS drug riluzole to restore cognitive function in cancer survivors.UCI Health places Watchman device with new innovative protocol
New protocol allows patients to be more comfortable while the watchman is performedUCI Health neuroscientist awarded $4.6 million for promising pan-cancer immunotherapy
Michael Demetriou, MD, PhD to advance his groundbreaking work on genetically modified chimeric antigen receptor CAR T-cells.